185 related articles for article (PubMed ID: 12969881)
1. beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content.
Stanley WC; Meadows SR; Kivilo KM; Roth BA; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1626-31. PubMed ID: 12969881
[TBL] [Abstract][Full Text] [Related]
2. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
[TBL] [Abstract][Full Text] [Related]
3. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.
Hall JL; Lopaschuk GD; Barr A; Bringas J; Pizzurro RD; Stanley WC
Cardiovasc Res; 1996 Nov; 32(5):879-85. PubMed ID: 8944819
[TBL] [Abstract][Full Text] [Related]
4. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
Kudo N; Barr AJ; Barr RL; Desai S; Lopaschuk GD
J Biol Chem; 1995 Jul; 270(29):17513-20. PubMed ID: 7615556
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.
King KL; Okere IC; Sharma N; Dyck JR; Reszko AE; McElfresh TA; Kerner J; Chandler MP; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1033-7. PubMed ID: 15821035
[TBL] [Abstract][Full Text] [Related]
6. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
7. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart.
Lopaschuk GD; Witters LA; Itoi T; Barr R; Barr A
J Biol Chem; 1994 Oct; 269(41):25871-8. PubMed ID: 7929291
[TBL] [Abstract][Full Text] [Related]
8. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis.
Atkinson LL; Fischer MA; Lopaschuk GD
J Biol Chem; 2002 Aug; 277(33):29424-30. PubMed ID: 12058043
[TBL] [Abstract][Full Text] [Related]
9. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
10. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
11. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
[TBL] [Abstract][Full Text] [Related]
12. Malonyl CoA control of fatty acid oxidation in the ischemic heart.
Dyck JR; Lopaschuk GD
J Mol Cell Cardiol; 2002 Sep; 34(9):1099-109. PubMed ID: 12392882
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid oxidation and the regulation of malonyl-CoA in human muscle.
Båvenholm PN; Pigon J; Saha AK; Ruderman NB; Efendic S
Diabetes; 2000 Jul; 49(7):1078-83. PubMed ID: 10909961
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation.
Goodwin GW; Taegtmeyer H
Am J Physiol; 1999 Oct; 277(4):E772-7. PubMed ID: 10516138
[TBL] [Abstract][Full Text] [Related]
15. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid oxidation in the reperfused ischemic heart.
Kantor PF; Dyck JR; Lopaschuk GD
Am J Med Sci; 1999 Jul; 318(1):3-14. PubMed ID: 10408755
[TBL] [Abstract][Full Text] [Related]
17. Regulation of myocardial fatty acid oxidation by substrate supply.
Longnus SL; Wambolt RB; Barr RL; Lopaschuk GD; Allard MF
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1561-7. PubMed ID: 11557544
[TBL] [Abstract][Full Text] [Related]
18. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation.
Chandler MP; Kerner J; Huang H; Vazquez E; Reszko A; Martini WZ; Hoppel CL; Imai M; Rastogi S; Sabbah HN; Stanley WC
Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1538-43. PubMed ID: 15191896
[TBL] [Abstract][Full Text] [Related]
19. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
Abu-Elheiga L; Matzuk MM; Abo-Hashema KA; Wakil SJ
Science; 2001 Mar; 291(5513):2613-6. PubMed ID: 11283375
[TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.
Hopkins TA; Dyck JR; Lopaschuk GD
Biochem Soc Trans; 2003 Feb; 31(Pt 1):207-12. PubMed ID: 12546686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
